AxTalis
Frank Vanderdonck is a seasoned professional with extensive experience in medical affairs, regulatory strategy, and business intelligence within the pharmaceutical industry. Currently serving as a Medical Affairs Consultant and Managing Partner at AxTalis since January 2020, Frank specializes in translating registration and access into launch strategies across the BeNeLux Nordics region. Previous roles include leadership positions at Avivia, Sandoz, Novartis, Chamaeleo Pharma, Ipsen, and UCB Pharma, where contributions ranged from project management and market access to competitive intelligence and medical education strategy. Frank holds a Master of Pharmaceutical Sciences from Ghent University and has a strong track record of driving growth, improving operational efficiencies, and enhancing the effectiveness of medical affairs teams.
This person is not in any teams
AxTalis
AxTalis is a consulting company that focuses on supporting pharma and medical device companies in Regulatory Affairs, Market Access, and Medical Affairs across the BeNeLux region. Our vision is to broaden the access to therapeutic solutions sustainably, driven by science, and through collaboration with physicians, researchers, companies, health authorities and patients. As the complexity of the healthcare environment increases, Regulatory Affairs, Market Access, and Medical Affairs functions are working closer together than ever to ensure sustained availability of therapeutic offerings. AxTalis mirrors a pharmaceutical affairs department, offering a dedicated cross-functional team as a service or individual plug-and-play components. Our strength lies in our people. The AxTalis crew is a blend of passionate, committed people with different backgrounds and experiences in the pharmaceutical industry. Thanks to its multicoloured traits, our team works closely with our clients to develop and implement value-adding projects with a broad view and understanding.